CN102409068A - A kind of preparation method of (3aS,6aR)-biotin chiral lactone - Google Patents
A kind of preparation method of (3aS,6aR)-biotin chiral lactone Download PDFInfo
- Publication number
- CN102409068A CN102409068A CN2011103704667A CN201110370466A CN102409068A CN 102409068 A CN102409068 A CN 102409068A CN 2011103704667 A CN2011103704667 A CN 2011103704667A CN 201110370466 A CN201110370466 A CN 201110370466A CN 102409068 A CN102409068 A CN 102409068A
- Authority
- CN
- China
- Prior art keywords
- lactone
- esterase
- microbacterium
- preparation
- methyl esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002596 lactones Chemical class 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 229960002685 biotin Drugs 0.000 title abstract description 34
- 239000011616 biotin Substances 0.000 title abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 25
- 108090000371 Esterases Proteins 0.000 claims abstract description 23
- 108090000790 Enzymes Proteins 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 14
- 241001658024 Microbacterium chocolatum Species 0.000 claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 239000000047 product Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000758 substrate Substances 0.000 claims abstract description 8
- 238000006722 reduction reaction Methods 0.000 claims abstract description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 5
- 239000011591 potassium Substances 0.000 claims abstract description 5
- 239000012295 chemical reaction liquid Substances 0.000 claims abstract 2
- 230000002829 reductive effect Effects 0.000 claims description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 230000000813 microbial effect Effects 0.000 claims description 8
- 239000011735 vitamin B7 Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 claims description 7
- 241001467578 Microbacterium Species 0.000 claims description 6
- 235000019219 chocolate Nutrition 0.000 claims description 6
- 238000007273 lactonization reaction Methods 0.000 claims description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 5
- 230000000284 resting effect Effects 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000013067 intermediate product Substances 0.000 claims description 4
- 239000012074 organic phase Substances 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 2
- 150000004702 methyl esters Chemical class 0.000 claims 9
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 claims 4
- 239000001110 calcium chloride Substances 0.000 claims 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims 3
- 239000000843 powder Substances 0.000 claims 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 2
- 229910000085 borane Inorganic materials 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- 229910000104 sodium hydride Inorganic materials 0.000 claims 2
- 239000012312 sodium hydride Substances 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000013016 damping Methods 0.000 claims 1
- 230000008021 deposition Effects 0.000 claims 1
- 238000003810 ethyl acetate extraction Methods 0.000 claims 1
- 239000012065 filter cake Substances 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- 238000001291 vacuum drying Methods 0.000 claims 1
- 150000002148 esters Chemical class 0.000 abstract description 26
- 238000000855 fermentation Methods 0.000 abstract description 6
- 230000004151 fermentation Effects 0.000 abstract description 6
- 239000002904 solvent Substances 0.000 abstract description 4
- 238000005265 energy consumption Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 239000012279 sodium borohydride Substances 0.000 abstract description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 abstract description 3
- 230000003197 catalytic effect Effects 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 6
- -1 cyclic imide Chemical class 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000000638 D-biotin Nutrition 0.000 description 3
- 239000011665 D-biotin Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229930003756 Vitamin B7 Natural products 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000011912 vitamin B7 Nutrition 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 108091007476 Microbial Esterases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
本发明公开了一种(3aS,6aR)-生物素手性内酯的制备方法,其特征在于采用巧克力微杆菌(Microbacteriumchocolatum)SIT101CGMCCNO.4436发酵生产酯酶,然后以内消旋二甲酯为该酶转化的底物,酶转化反应液中的产物经酸化、溶剂萃取、浓缩、干燥后得(4S,5R)-半甲酯再与还原剂硼氢化钠或硼氢化钾在无水乙醇中进行还原反应18-30h,所得还原产物经内酯化、沉淀和干燥后最终得到(3aS,6aR)-生物素手性内酯。本发明的制备方法具有反应条件温和、催化效率高、最终产物收率高及生产成本低的特点,同时具有较低的能量消耗、物料消耗和三废产出,适于大规模的生产。
The invention discloses a method for preparing a (3a S , 6a R )-biotin chiral lactone, which is characterized in that esterase is produced by fermentation with Microbacteriumchocolatum SIT101CGMCCNO.4436, and then meso-dimethyl ester is used as a substrate for the enzyme conversion. The product in the enzyme conversion reaction liquid is acidified, solvent extracted, concentrated, and dried to obtain (4 S , 5 R )-semimethyl ester, which is then subjected to reduction reaction with a reducing agent, sodium borohydride or potassium borohydride, in anhydrous ethanol for 18-30 hours. The obtained reduction product is lactonized, precipitated, and dried to finally obtain (3a S , 6a R )-biotin chiral lactone. The preparation method of the invention has the characteristics of mild reaction conditions, high catalytic efficiency, high final product yield, and low production cost, and at the same time has low energy consumption, material consumption, and three wastes output, and is suitable for large-scale production.
Description
技术领域 technical field
本发明涉及一种(3aS,6aR)-生物素手性内酯的制备方法,特别涉及一种利用利用巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436 进行发酵产酶,并进行酶催化内消旋二酯的不对称水解制备(4S,5R)-半甲酯,半甲酯经还原剂还原、内酯化得到(3aS, 6aR)-生物素手性内酯的方法。 The present invention relates to a preparation method of (3a S ,6a R )-biotin chiral lactone, in particular to a method for producing enzyme by fermentation using Microbacterium chocolatum SIT101 CGMCC NO.4436, and performing enzyme-catalyzed internal Asymmetric hydrolysis of racemic diester to prepare (4 S ,5 R )-hemimethyl ester, and hemimethyl ester is reduced by reducing agent and lactonized to obtain (3a S , 6a R )-biotin chiral lactone.
背景技术 Background technique
已知如式(I)所示的(3aS, 6aR)-生物素手性内酯是合成d-生物素(d-Biotin,又名维生素H和辅酶R)的关键手性中间体,其结构式(I)如下所示: It is known that (3a S , 6a R )-biotin chiral lactone shown in formula (I) is a key chiral intermediate for the synthesis of d -biotin ( d -Biotin, also known as vitamin H and coenzyme R), which Structural formula (I) is as follows:
d-生物素又名维生素H,是水溶性B簇维生素之一。它是羧化酶的辅酶,也是糖、蛋白质和脂肪中间代谢中的一个重要辅酶。除了一部分细菌,酵母和植物能自身合成生物素外,几乎所有的动物和一部分微生物都要从外源获得生物素。生物素用途广泛,20-30%用于医用原料,50%用于饲料,另外还用作化妆品原料、营养添加剂等。 d -Biotin, also known as vitamin H, is one of the water-soluble B vitamins. It is a coenzyme of carboxylase and an important coenzyme in the intermediate metabolism of sugar, protein and fat. Except some bacteria, yeast and plants can synthesize biotin by themselves, almost all animals and some microorganisms need to obtain biotin from exogenous sources. Biotin has a wide range of uses, 20-30% is used for medical raw materials, 50% is used for feed, and it is also used as cosmetic raw materials and nutritional additives.
已报道的(3aS,6aR)-生物素手性内酯合成方法主要有拆分法、不对称合成和生物合成。 The reported synthesis methods of (3a S ,6a R )-biotin chiral lactone mainly include resolution method, asymmetric synthesis and biosynthesis.
化学方法拆分,如利用光学活性薄荷醇或手性胺麻黄碱拆分前体物质,再转化得到右旋生物素中间体内酯。化学拆分法的缺点是拆分剂价格昂贵,分离不完全,还有环境污染和毒性问题。物理方法拆分,如用诱导结晶拆分前体半甲酯,再还原得到右旋生物素中间体内酯,条件控制要求高,光学纯度差,收率低。 Chemical resolution, such as using optically active menthol or chiral amine ephedrine to resolve precursor substances, and then converting to obtain D-biotin intermediate lactone. The disadvantages of the chemical resolution method are that the resolution agent is expensive, the separation is not complete, and there are environmental pollution and toxicity problems. Physical separation, such as the use of induced crystallization to resolve the precursor hemimethyl ester, and then reduction to obtain the D-biotin intermediate lactone, requires high condition control, poor optical purity, and low yield. the
目前工业上主要采取还原不对称环酰亚胺的方法来制备(3aS,6aR)-生物素手性内酯(Tetrahedron. Lett., 1999, 40, 8873-8876.)。在合成过程中引入与底物相同摩尔当量的手性胺与二酸底物形成手性环酰亚胺,再经化学还原、内酯化关环得到生物素手性内酯。该方法因为引入了昂贵的手性胺,成本较高,三废处理较为复杂。 At present, the industry mainly adopts the method of reducing asymmetric cyclic imide to prepare (3a S ,6a R )-biotin chiral lactone (Tetrahedron. Lett., 1999, 40, 8873-8876.). During the synthesis process, a chiral amine with the same molar equivalent as the substrate is introduced to form a chiral cyclic imide with a diacid substrate, and then undergoes chemical reduction and lactonization ring closure to obtain a biotin chiral lactone. Because the method introduces expensive chiral amines, the cost is high, and the treatment of the three wastes is relatively complicated.
近年来,也有文献报道了生物催化制备的方法。例如日本学者(Agric. Biol Chem.,1982, 46(7), 1907)用猪肝酯酶不对称水解前手性二丙酯得到光学活性单酯,再经硼氢化锂还原得到右旋生物素中间体内酯,产率为85%,ee值为75%。陈芬儿等(Adv.Synth.Catal.2005,347,549)用固定化猪肝酯酶催化前手性二甲酯水解,产物手性半甲酯(ee值为91%)经重结晶、化学还原内酯化后得到手性内酯,产率约为60%。利用酯酶催化不对称水解内消旋二酯的方法理论上可以以100%的产率得到光学纯的单酯产物,克服了传统动力学拆分50%的理论局限性,而且避免了传统拆分剩余底物需要化学消旋的弊端。与化学还原不对称环酰亚胺的方法比,不需要引入手性胺,因此将有效的减小生产物料的成本和生产废水中有机物的含量,结合酶催化特有的反应条件温和、选择性高、能耗小等优点,是很有希望的取代现有化学工艺的新方法。目前存在的主要问题是猪肝酯酶的选择性不够高,得到的半甲酯需要重结晶后才能进行化学还原,这样导致手性内酯的收率偏低,仅为60%左右,并且猪肝酯酶价格昂贵,其动物来源限制了催化剂的大规模获得与使用,从而限制了(3aS,6aR)-生物素手性内酯的大规模生产。 In recent years, there are also literatures reporting the method of biocatalytic preparation. For example, Japanese scholars (Agric. Biol Chem., 1982, 46(7), 1907) used pig liver esterase to asymmetrically hydrolyze prochiral dipropyl ester to obtain optically active monoester, and then reduced it with lithium borohydride to obtain D-biotin Intermediate lactone, the yield is 85%, and the ee value is 75%. Chen Fen'er et al. (Adv.Synth.Catal.2005,347,549) used immobilized porcine liver esterase to catalyze the hydrolysis of prochiral dimethyl esters, and the product chiral hemimethyl esters (ee value 91%) were recrystallized and chemically reduced The chiral lactone is obtained after lactonization, and the yield is about 60%. The method of using esterase to catalyze the asymmetric hydrolysis of meso diester can theoretically obtain optically pure monoester products with 100% yield, which overcomes the theoretical limitation of 50% of traditional kinetic resolution and avoids the traditional resolution. Disadvantages of chemical racemization are required to divide the remaining substrate. Compared with the method of chemical reduction of asymmetric cyclic imide, there is no need to introduce chiral amine, so it will effectively reduce the cost of production materials and the content of organic matter in production wastewater, combined with the mild reaction conditions and high selectivity unique to enzyme catalysis , low energy consumption and other advantages, is a promising new method to replace the existing chemical process. The main problem existing at present is that the selectivity of pig liver esterase is not high enough, and the obtained hemimethyl ester needs to be recrystallized before it can be chemically reduced, which leads to a low yield of chiral lactone, only about 60%, and pig liver Liver esterase is expensive, and its animal origin limits the large-scale acquisition and use of catalysts, thereby limiting the large-scale production of (3a S ,6a R )-biotin chiral lactone.
发明内容 Contents of the invention
本发明的目的在于为了解决上述技术问题而提供一种(3aS,6aR)-生物素手性内酯的制备方法,即将巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436作为生物催化剂高选择性地催化内消旋二甲酯(III)不对称水解产生(4S,5R)-半甲酯(II),所得(4S,5R)-半甲酯(II)经化学还原、内酯化合成为(3aS,6aR)-生物素手性内酯(I)。 The purpose of the present invention is to provide a preparation method of (3a S ,6a R )-biotin chiral lactone in order to solve the above technical problems, that is to use Microbacterium chocolate SIT101 CGMCC NO.4436 as a biocatalyst with high selectivity Catalyzed asymmetric hydrolysis of meso dimethyl ester (III) to produce (4 S ,5 R )-hemimethyl ester (II), the obtained (4 S ,5 R )-hemimethyl ester (II) was chemically reduced, internally Esterification into (3a S ,6a R )-biotin chiral lactone (I).
其中(4S,5R)-半甲酯(II)的结构式如下: Wherein the structural formula of (4 S ,5 R )-hemimethyl ester (II) is as follows:
内消旋二甲酯(III)的结构式如下: The structural formula of meso dimethyl ester (III) is as follows:
。 .
本发明采用的技术方案 The technical scheme adopted in the present invention
一种(3aS,6aR)-生物素手性内酯的制备方法,即采用高产酯酶的巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436(该菌株已于2010年12月8日保藏于中国微生物菌种保藏管理委员会普通微生物中心)发酵生产酯酶,然后以内消旋二甲酯为该酯酶转化的底物,酯酶转化反应液中的产物经酸化、溶剂萃取、浓缩、干燥后得(4S,5R)-半甲酯(II),(4S,5R)-半甲酯(II)再与还原剂硼氢化钠或硼氢化钾在无水乙醇中进行还原反应18-30h,所得还原产物经内酯化、沉淀和干燥后最终得到高光学纯度的(3aS,6aR)-生物素手性内酯(I)。 A method for preparing (3aS, 6aR)-biotin chiral lactone, namely using Microbacterium chocolatum SIT101 CGMCC NO.4436 with high esterase yield Strain Preservation Management Committee General Microbiology Center) to produce esterase by fermentation, and then use meso-dimethyl ester as the substrate for the esterase conversion, and the product in the esterase conversion reaction solution is acidified, solvent extracted, concentrated, and dried to obtain ( 4S,5R)-hemimethyl ester (II), (4S,5R)-hemimethyl ester (II) and reducing agent sodium borohydride or potassium borohydride in absolute ethanol for 18-30h, the resulting reduction product After lactonization, precipitation and drying, the (3aS,6aR)-biotin chiral lactone (I) with high optical purity was finally obtained.
附图说明 Description of drawings
上述的(3aS,6aR)-生物素手性内酯制备过程反应示意图如图1。 The reaction schematic diagram of the above (3a S ,6a R )-biotin chiral lactone preparation process is shown in Fig. 1 .
上述制备方法所得的(3aS,6aR)-生物素手性内酯的ee值为98.0%,熔点121.0-121.7℃,(C=1,氯仿)。 The (3a S ,6a R )-biotin chiral lactone obtained by the above preparation method has an ee value of 98.0% and a melting point of 121.0-121.7°C. (C=1, chloroform).
本发明的技术效果 Technical effect of the present invention
本发明的一种(3aS,6aR)-生物素手性内酯的制备方法,即通过微生物酶水解制造中间产物(4S,5R)-半甲酯,再与还原剂反应后经内酯化反应生成(3aS,6aR)-生物素手性内酯的方法,由于采用了高活性和选择性的微生物酯酶为催化剂,反应条件温和、催化效率高、半甲酯的光学纯度高,可以无需结晶,直接被还原剂还原,经内酯化后生成高光学纯度的(3aS, 6aR)-生物素手性内酯,同时具有较高的收率。因此具有比现有化学法更低的能量消耗、物料消耗和三废产出。 A preparation method of (3a S , 6a R )-biotin chiral lactone of the present invention, that is, the intermediate product (4 S , 5 R )-hemimethyl ester is produced by microbial enzyme hydrolysis, and then reacted with a reducing agent and then internally The method of esterification reaction to generate (3a S ,6a R )-biotin chiral lactone, due to the use of highly active and selective microbial esterase as a catalyst, the reaction conditions are mild, the catalytic efficiency is high, and the optical purity of hemimethyl ester is high , can be directly reduced by a reducing agent without crystallization, and (3a S , 6a R )-biotin chiral lactone with high optical purity can be generated after lactonization with a high yield. Therefore, it has lower energy consumption, material consumption and output of three wastes than the existing chemical method.
而且本发明的一种(3aS, 6aR)-生物素手性内酯的制备方法,无需添加任何手性拆分剂,进一步节约了成本。与采用猪肝酯酶制备(3aS, 6aR)-生物素手性内酯的方法比较,本发明的一种(3aS, 6aR)-生物素手性内酯制备方法具有生产成本低而选择性更高,可以以较低的成本大规模的生产,因此比猪肝酯酶的方法具有更高的应用价值。 Moreover, the preparation method of a (3a S , 6a R )-biotin chiral lactone of the present invention does not need to add any chiral resolving agent, which further saves the cost. Compared with the method of preparing (3a S , 6a R )-biotin chiral lactone by using pig liver esterase, the method for preparing (3a S , 6a R )-biotin chiral lactone of the present invention has the advantages of low production cost and can be selected Higher in nature and can be mass-produced at a lower cost, so it has higher application value than the pig liver esterase method.
图1、(3aS,6aR)-生物素手性内酯制备过程反应示意图。 Figure 1. Schematic diagram of the preparation process of (3a S ,6a R )-biotin chiral lactone.
具体实施方式 Detailed ways
下面通过实施例对本发明进一步详细描述,但并不限制本发明。 The present invention is described in further detail below by way of examples, but the present invention is not limited. the
本发明所用的试剂皆为分析纯或化学纯规格。 The reagents used in the present invention are all analytically pure or chemically pure. the
本发明用的内消旋二甲酯的制备方法: The preparation method of the meso-dimethyl ester used in the present invention :
将内消旋的二酸(28.32g,0.08mol),无水甲醇(16.2mL,0.4mol),浓硫酸 (0.4mL,7.5mmol)和苯(65mL)在搅拌条件下加热回流6 h,减压除掉溶剂,剩余物加入水(40mL)和乙酸乙酯(40mL),有机相分层后,水相再用乙酸乙酯(10mL)萃取3次,合并乙酸乙酯相,分别用2M Na2CO3 (共3次,每次5ml)和水(共4次,每次5ml)洗涤。之后用无水硫酸钠干燥,减压除掉溶剂后得到内消旋二甲酯(III),收率为92%,纯度为99%。 The meso-diacid (28.32g, 0.08mol), anhydrous methanol (16.2mL, 0.4mol), concentrated sulfuric acid (0.4mL, 7.5mmol) and benzene (65mL) were heated to reflux for 6 h under stirring conditions, and The solvent was removed by pressure, and water (40mL) and ethyl acetate (40mL) were added to the residue. After the organic phase was separated, the aqueous phase was extracted three times with ethyl acetate (10mL). The ethyl acetate phases were combined and washed with 2M Na 2 CO 3 (3 times in total, 5ml each time) and water (4 times in total, 5ml each time) for washing. After drying with anhydrous sodium sulfate, the solvent was removed under reduced pressure to obtain meso-dimethyl ester (III), with a yield of 92% and a purity of 99%.
SR半甲酯的检测方法:手性液相色谱(色谱柱为Chiralcel OJ-H色谱柱,流动相为正己烷:异丙醇:三氟乙酸=92:8:0.1,紫外检测波长220nm,流速0.5ml/min); The detection method of SR hemimethyl ester : chiral liquid chromatography (the chromatographic column is Chiralcel OJ-H chromatographic column, the mobile phase is n-hexane:isopropanol:trifluoroacetic acid=92:8:0.1, the ultraviolet detection wavelength is 220nm, the flow rate 0.5ml/min);
(3aS,6aR)-内酯的检测方法:手性液相色谱(色谱柱为Chiralcel OD-H色谱柱,流动相为正己烷:异丙醇=80:20,紫外检测波长210nm,流速1.0ml/min); (3a S ,6a R )-lactone detection method: Chiral liquid chromatography (the chromatographic column is a Chiralcel OD-H chromatographic column, the mobile phase is n-hexane:isopropanol=80:20, the ultraviolet detection wavelength is 210nm, and the flow rate is 1.0ml/min);
(4S,5R)-半甲酯的收率以内消旋二甲酯为底物计算; The yield of (4 S ,5 R )-hemimethyl ester was calculated using meso-dimethyl ester as substrate;
(3aS, 6aR)-生物素手性内酯的收率以(4S,5R)-半甲酯为底物计算。 The yield of (3a S , 6a R )-biotin chiral lactone was calculated using (4 S ,5 R )-hemimethyl ester as substrate.
实施例1Example 1
一种(3aS,6aR)-生物素手性内酯的制备方法,包括如下制备步骤: A preparation method of (3a S , 6a R )-biotin chiral lactone, comprising the following preparation steps:
(1)、(4S,5R)-半甲酯(II)的制备 (1) Preparation of (4 S ,5 R )-hemimethyl ester (II)
①、菌种的斜面培养 ① Incline culture of strains
取冰箱4℃保存的巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436菌种,取出后接种到斜面培养基上,在30 oC下培养48 h,得巧克力微杆菌(Microbacterium chocolatum) SIT101斜面种子,并将其保存在4℃的冰箱中; Take the Microbacterium chocolatum SIT101 CGMCC NO.4436 strain stored in the refrigerator at 4°C, take it out, inoculate it on the slant medium, and cultivate it at 30 o C for 48 hours to obtain the slant seeds of Microbacterium chocolatum SIT101 , and store it in a refrigerator at 4°C;
所述的斜面培养基:葡萄糖15.0 g/L,酵母膏5.0 g/L,蛋白胨10.0 g/L,MgSO4 1g/L,琼脂15-20g/L,pH7.0; The slant medium: glucose 15.0 g/L, yeast extract 5.0 g/L, peptone 10.0 g/L, MgSO 4 1g/L, agar 15-20 g/L, pH7.0;
②、产酶发酵培养 ②, Enzyme production fermentation culture
取4oC保存的巧克力微杆菌(Microbacterium chocolatum) SIT101 CGMCC NO.4436斜面种子,挑取一环接种至装有50ml发酵培养基的250ml摇瓶中,在30℃下,160rpm振摇培养48h,以10000g离心约15min得到含酯酶的巧克力微杆菌(Microbacterium chocolatum) SIT101静息细胞; Take Microbacterium chocolatum SIT101 CGMCC NO.4436 slant seeds preserved at 4 o C, pick a loop and inoculate it into a 250ml shaker flask containing 50ml of fermentation medium, and culture it at 30°C with shaking at 160rpm for 48h. Centrifuge at 10,000 g for about 15 minutes to obtain resting cells of Microbacterium chocolatum SIT101 containing esterase;
所述的发酵培养基:葡萄糖15.0g/L,酵母膏5.0g/L,蛋白胨10.0g/L,MgSO4 1g/L,pH7.0; The fermentation medium: glucose 15.0g/L, yeast extract 5.0g/L, peptone 10.0g/L, MgSO 4 1g/L, pH7.0;
③、(4S,5R)-半甲酯(II)的制备 ③. Preparation of (4 S ,5 R )-hemimethyl ester (II)
取湿重为7g的步骤(2)所得的含酯酶的巧克力微杆菌(Microbacterium chocolatum) SIT101静息细胞,悬浮于95ml浓度为0.1M,pH8.0的磷酸钠盐缓冲溶液中,加入内消旋二甲酯7mmol,再加入5ml二甲基亚砜,反应混合物在30℃、160r/min的恒温摇床上振摇反应48h后,加入2mol/L盐酸调水相pH值到2.0,用乙酸乙酯萃取酸化液3次,每次乙酸乙酯的用量为30ml,合并有机相并用无水硫酸钠干燥,之后减压蒸干有机相得到(4S,5R)-半甲酯,其收率为88%,纯度为98%,ee值大于99%; Take the esterase-containing Microbacterium chocolatum ( Microbacterium chocolatum ) SIT101 resting cells obtained in step (2) with a wet weight of 7 g, suspend them in 95 ml of sodium phosphate buffer solution with a concentration of 0.1 M, pH 8.0, and add internal Spin 7 mmol of dimethyl ester, then add 5 ml of dimethyl sulfoxide, shake the reaction mixture on a constant temperature shaker at 30 °C and 160 r/min for 48 h, add 2 mol/L hydrochloric acid to adjust the pH value of the water phase to 2.0, and use ethyl acetate Ester extraction acidified liquid 3 times, the consumption of each ethyl acetate is 30ml, combine organic phase and dry with anhydrous sodium sulfate, then evaporate organic phase under reduced pressure to obtain (4 S , 5 R )-hemimethyl ester, its yield 88%, the purity is 98%, and the ee value is greater than 99%;
(2)、(3aS,6aR)-生物素手性内酯的制备 (2) Preparation of (3a S ,6a R )-biotin chiral lactone
取采用步骤(1)的方法制得的(4S,5R)-半甲酯0.78g(2mmol)、无水氯化钙0.22g(2mmol)溶解于10mL无水乙醇中,然后控制温度在0℃,加入0.23g(6mmol)硼氢化钠,加入完毕后撤去冰浴,室温下搅拌反应30h,升温至55~60℃,加入5%盐酸溶液6mL,反应30min,TLC监测反应进程,待底物完全反应后,加入10mL蒸馏水,再放在冰水浴中冷却,出现无色沉淀,经过滤干燥后,最终得(3aS,6aR)-生物素手性内酯0.52g,收率为89%,ee值为97.8%。 Dissolve 0.78g (2mmol) of ( 4S , 5R )-hemimethylester and 0.22g (2mmol) of anhydrous calcium chloride in 10mL of absolute ethanol, and then control the temperature at 0°C, add 0.23g (6mmol) sodium borohydride, remove the ice bath after the addition is complete, stir the reaction at room temperature for 30h, raise the temperature to 55~60°C, add 5% hydrochloric acid solution 6mL, react for 30min, TLC monitors the reaction process, and waits until the bottom After the product was completely reacted, 10 mL of distilled water was added, and then cooled in an ice-water bath, a colorless precipitate appeared, and after filtration and drying, 0.52 g of (3a S , 6a R )-biotin chiral lactone was finally obtained, with a yield of 89%. , ee value is 97.8%.
实施例2Example 2
一种(3aS,6aR)-生物素手性内酯的制备方法,包括如下制备步骤: A preparation method of (3a S , 6a R )-biotin chiral lactone, comprising the following preparation steps:
(1)、(4S,5R)-半甲酯(II)的制备,同实施例1; (1), the preparation of (4 S ,5 R )-hemimethyl ester (II), the same as in Example 1;
(2)、(3aS,6aR)-生物素手性内酯的制备 (2) Preparation of (3a S ,6a R )-biotin chiral lactone
取采用步骤(1)的方法制得的(4S,5R)-半甲酯7.8g(20mmol)、无水氯化钙2.22g(20mmol)溶解于100mL无水乙醇中,然后控制温度在0℃,加入3.2g(60mmol)硼氢化钾,加入完毕后撤去冰浴,室温下搅拌反应18h,升温至55~60℃,加入5%盐酸溶液60mL,反应30min,TLC监测反应进程,待底物完全反应后,加入100mL蒸馏水,再放在冰水浴中冷却,出现无色沉淀,经过滤干燥后,最终得(3aS,6aR)-生物素手性内酯5.3克,收率为91%,ee值为98.0%,熔点121.0-121.7℃,(C=1,氯仿)。 Take (4 S ,5 R )-hemimethyl ester 7.8g (20mmol) and anhydrous calcium chloride 2.22g (20mmol) prepared by the method of step (1) and dissolve them in 100mL absolute ethanol, then control the temperature at 0°C, add 3.2g (60mmol) potassium borohydride, remove the ice bath after the addition, stir and react at room temperature for 18h, heat up to 55~60°C, add 60mL of 5% hydrochloric acid solution, react for 30min, monitor the reaction progress by TLC, wait until the bottom After the product was completely reacted, 100 mL of distilled water was added, and then cooled in an ice-water bath, a colorless precipitate appeared, and after filtration and drying, 5.3 grams of (3a S , 6a R )-biotin chiral lactone was finally obtained, with a yield of 91%. , ee value is 98.0%, melting point is 121.0-121.7℃, (C=1, chloroform).
以上所述内容仅为本发明构思下的基本说明,而依据本发明的技术方案所作的任何等效变换,均应属于本发明的保护范围。 The above content is only a basic description of the concept of the present invention, and any equivalent transformation made according to the technical solution of the present invention shall fall within the scope of protection of the present invention. the
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110370466.7A CN102409068B (en) | 2011-11-21 | 2011-11-21 | Preparation method for (3aS, 6aR)-biotin chiral lactone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110370466.7A CN102409068B (en) | 2011-11-21 | 2011-11-21 | Preparation method for (3aS, 6aR)-biotin chiral lactone |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102409068A true CN102409068A (en) | 2012-04-11 |
CN102409068B CN102409068B (en) | 2014-03-26 |
Family
ID=45911407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110370466.7A Active CN102409068B (en) | 2011-11-21 | 2011-11-21 | Preparation method for (3aS, 6aR)-biotin chiral lactone |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102409068B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103409478A (en) * | 2013-06-21 | 2013-11-27 | 浙江圣达药业有限公司 | Method for synthesizing biotin intermediate lactone through chemical enzyme method |
CN107686488A (en) * | 2016-08-05 | 2018-02-13 | 浙江医药股份有限公司新昌制药厂 | A kind of synthetic method of biotin intermediate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101284837A (en) * | 2008-06-05 | 2008-10-15 | 复旦大学 | Stereoselective Total Synthesis of (+)-Biotin |
CN102120977A (en) * | 2010-12-24 | 2011-07-13 | 上海应用技术学院 | Microbacterium chocolatum and method for preparing (4S,5R)-half ester by using same |
-
2011
- 2011-11-21 CN CN201110370466.7A patent/CN102409068B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101284837A (en) * | 2008-06-05 | 2008-10-15 | 复旦大学 | Stereoselective Total Synthesis of (+)-Biotin |
CN102120977A (en) * | 2010-12-24 | 2011-07-13 | 上海应用技术学院 | Microbacterium chocolatum and method for preparing (4S,5R)-half ester by using same |
Non-Patent Citations (2)
Title |
---|
夏仕文等: "酶在光学活性药物合成中的应用", 《合成化学》 * |
陈芬儿等: "d-生物素的不对称全合成研究(Ⅴ)", 《高等学校化学学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103409478A (en) * | 2013-06-21 | 2013-11-27 | 浙江圣达药业有限公司 | Method for synthesizing biotin intermediate lactone through chemical enzyme method |
CN103409478B (en) * | 2013-06-21 | 2015-01-28 | 浙江圣达药业有限公司 | Method for synthesizing biotin intermediate lactone through chemical enzyme method |
CN107686488A (en) * | 2016-08-05 | 2018-02-13 | 浙江医药股份有限公司新昌制药厂 | A kind of synthetic method of biotin intermediate |
Also Published As
Publication number | Publication date |
---|---|
CN102409068B (en) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112368262B (en) | Method for preparing pregabalin intermediate (R) -3- (carbamoylmethyl) -5-methylhexanoic acid | |
Tamborini et al. | Biotransformation with whole microbial systems in a continuous flow reactor: resolution of (RS)-flurbiprofen using Aspergillus oryzae by direct esterification with ethanol in organic solvent | |
CN103243134A (en) | Fermentation production method based on epothilone B metabolic pathways | |
CN102719378B (en) | Method for preparing (-) gamma-lactam by catalysis asymmetry of microorganism | |
CN102409068B (en) | Preparation method for (3aS, 6aR)-biotin chiral lactone | |
CN102120977B (en) | Microbacterium chocolatum and method for preparing (4S,5R)-half ester by using same | |
CN100489085C (en) | Red yeast cell and method of producing optically pure chiral tertiary alcohol | |
CN105567584B (en) | A kind of (+/-) gamma-lactam that can split obtains bacillus and its screening and application of (+) gamma-lactam | |
CN104651425B (en) | A kind of method of living things catalysis synthesizing optical active al lactone | |
CN101205548A (en) | Application of Saccharomyces cerevisiae in the preparation of (S)-(-)-3-chloro-1-phenylpropanol | |
CN101709322A (en) | Method for synthesizing betulic acid by carrying out biocatalysis on betulin | |
CN108410749B (en) | Method for preparing (-)γ-lactam by asymmetric hydrolysis of marine low temperature (+)γ-lactamase | |
CN102465159B (en) | Synthesis process for preparing eslicarbazepine with microbial method | |
CN101864370B (en) | Yeast strain converting quinuclidone into R-3-quinuclidinol and conversion method thereof | |
CN101824438B (en) | Method for preparing (S)-3-hydroxy butyric acid ethyl ester through ethyl acetoacetate microbial conversion | |
CN105586289B (en) | A kind of (+/-) gamma-lactam that can split obtains pseudomonad and its screening and application of (-) gamma-lactam | |
CN103589665A (en) | Rhodococcus qingshengii and application thereof in preparation of ethyl (S)-4-chloro-3-hydroxy butyrate | |
CN103114122A (en) | Method for preparing trans-4-aminomethyl-naphthenic acid from Actioplanes sp. | |
CN102925500A (en) | Preparation method of chiral 4-hydroxy-4 phenyl butyric acid ester | |
CN102925368B (en) | Beauveria bassiana capable of catalyzing an asymmetric reduction reaction and its application | |
CN101186938B (en) | A kind of preparation method of D-biotin intermediate lactone | |
CN106086090A (en) | A kind of method that two-step microbial conversion method prepares R mandelic acid | |
CN1778889A (en) | Bacteria and method for preparing (S)-4-chloro-3-hydroxybutyrate by biocatalysis | |
Zheng et al. | Chemoenzymatic synthesis of d-biotin intermediate lactone via lipase-catalyzed desymmetrization of meso diols | |
CN102719497B (en) | Method for preparing methyl (S)-(+)-mandelate by microbial transformation of methyl benzoylformate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: ZHENGJIANG SHENGDA BIO-PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: ZHEJIANG SHENGDA PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 317200 No. 789, Renmin East Road, Chicheng street, Tiantai County, Zhejiang Patentee after: ZHEJIANG SHENGDA BIO-PHARM CO., LTD. Patentee after: Shanghai Institute of Technology Address before: 317200, Zhejiang City, Taizhou province Tiantai Road East Road Extension Patentee before: Zhejiang Shengda Pharmaceutical Co., Ltd. Patentee before: Shanghai Institute of Technology |